Navigation Links
Behind a marine creature's bright green fluorescent glow
Date:7/1/2014

Pushing closer to understanding the mechanisms behind the mysterious glow of light produced naturally by certain animals, scientists at Scripps Institution of Oceanography at UC San Diego have deciphered the structural components related to fluorescence brightness in a primitive sea creature.

In a study published in Scientific Reports, an open-access journal of the Nature Publishing Group, Dimitri Deheyn and his colleagues at Scripps Oceanography, the Air Force Research Laboratory, and the Salk Institute for Biological Studies have conducted the most detailed examination of green fluorescent proteins (GFPs) in lancelets, marine invertebrates also known as "amphioxus." The fish-shaped animals, which spend much of their time in shallow coastal regions burrowed in sand except for their heads, offer unique insights on natural fluorescence since individual specimens can emit both very bright and much dimmer versions of the light, a rare capability in the animal kingdom.

The study carries implications for a variety of industries looking to maximize brightness of natural fluorescencethe process of transformation of blue "excitation" light into green "emission" lightincluding applications in biotechnology such as adapting fluorescence for biomedical protein tracers and for tracking the expression of specific genes in the human body.

In investigating the structural differences between the proteins with the two levels of light output, known to be generated by the GFPs inside amphioxus, Deheyn and his colleagues found that only a few key structural differences at the nanoscale allows the sea creature to emit different brightness levels. The differences relate to changes in stiffness around the animal's "chromophore pocket," the area of proteins responsible for molecular transformation of light, and thus light output intensity.

"We discovered that some of the amphioxus GFPs are able to transform blue light into green light with 10
'/>"/>

Contact: Mario Aguilera or Robert Monroe
scrippsnews@ucsd.edu
858-534-3624
University of California - San Diego
Source:Eurekalert

Page: 1 2

Related biology news :

1. New insight into mechanisms behind autoimmune diseases suggests a potential therapy
2. Culprit behind unchecked angiogenesis identified
3. Nowhere to hide: New device sees bacteria behind the eardrum
4. New report puts real numbers behind history of oyster reefs
5. Delving into the molecular mechanism behind deep-sea bacterias pressure tolerance
6. U OF A expert pinpoints nutrient behind fresh water algae blooms
7. Researchers describe new molecular interactions behind the inhibition of TGF beta-signaling
8. Behind closed doors: Researchers show how probiotics boost plant immunity
9. Researchers discover 2 genetic flaws behind common form of inherited muscular dystrophy
10. Scientists sniff out the substances behind the aroma in the king of fruits
11. Researchers find new genetic pathway behind neurodevelopmental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/9/2015)... April 9, 2015 Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 2015, after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
(Date:4/2/2015)... April 2, 2015 At its 2015 ACMG ... City , the American College of Medical Genetics ... directors to its Board.  Members of the ACMG Board ... for forming and advancing its policies and programs. ACMG ... "It,s an eventful time in medical genetics ...
(Date:4/1/2015)...   Medisafe ™, the leading global medication management ... and Android smartphones and tablets, announces ... platform to allow patients to track and correlate their ... patients will be able to visualize in real-time how ... such as glucose levels and blood pressure. ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
... release is available in German . ... infants was investigated using the prominent ,Stanford Marshmallow Experiment,: the children ... eat it now or wait and receive a second one if ... several minutes. Interestingly, children that were able to wait for the ...
... March 13, 2013, Shenzhen, China - In a collaborative study ... Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, ... of wild rice Oryza brachyantha . This work provides ... of Oryza genomes. The genus Oryza ...
... up and walked on two legs is considered to be one ... gone to the far ends of the earth and the ... we walk the way we walk. In the latest such ... Africa) have taken a closer look at bipedal kangaroos and wallabies ...
Cached Biology News:Doing business with a parrot 2Whole genome sequencing of wild rice reveals the mechanisms underlying oryza genome evolution 2It's all in the way we move 2
(Date:4/28/2015)... 2015 According to a 2013 report ... receive medical treatment from burn injuries per year. Despite ... extensive formation of scars with subsequent contractures remains a ... which there is no adequate treatment. Contractures are a ... and can cause permanent deformity. , Synedgen has ...
(Date:4/28/2015)... Spartan Bioscience today announced that Paul ... by the Ottawa Chamber of Commerce as one of ... selected from over 240 applicants based on his business ... Spartan, Dr. Lem founded Plexagen Diagnostics, and also served ... a Medical Degree from the University of Ottawa, and ...
(Date:4/27/2015)... 27, 2015  For about a century, a ... ability to utilize and catabolize glucose at a ... is called the ,Warburg phenomenon", that is an ... oxygen presence, leading to enhanced lactate generation. Even ... choose glucose fermentation. A variety of such abnormalities ...
(Date:4/27/2015)... San Diego, Calif. (PRWEB) April 27, 2015 ... mechanisms of drug and chemical toxicity carries implications for ... featured speaker April 28 at National University , ... reception and presentation by Dr. Hanzlik, a professor at ... in drug metabolism and drug design, starts at 5 ...
Breaking Biology Technology:Synedgen Burn Treatment Results Presented at Premier Wound Conference 2Synedgen Burn Treatment Results Presented at Premier Wound Conference 3Spartan Bioscience Announces Paul Lem Named Ottawa’s Top 40 Under 40 2Study Indicates Cancer Cells Alter Glucose Metabolism to Enhance Energy Production and Cell Growth 2Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 2Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 3
... ,, BEIJING, China , May ... or the "Company") a leading developer,manufacturer, and distributor of Shengmingsu brand ... ("PRC"), today announced its,financial results for the quarter ended ... 2010 Highlights, -- Revenue increased 100.5% to $24.9 ...
... RESEARCH TRIANGLE PARK, N.C. , May 12 The International ... Trials and Statistics Unit, is running the Intergroup Exemestane Study (IES).  IES ... early breast cancer and a median follow-up period of 91 months. ... from multiple centers. , , ...
... schedule , , , ... , , ... announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a ... of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and ...
Cached Biology Technology:Yongye International Announces First Quarter 2010 Results 2Yongye International Announces First Quarter 2010 Results 3Yongye International Announces First Quarter 2010 Results 4Yongye International Announces First Quarter 2010 Results 5Yongye International Announces First Quarter 2010 Results 6Yongye International Announces First Quarter 2010 Results 7Yongye International Announces First Quarter 2010 Results 8Yongye International Announces First Quarter 2010 Results 9Yongye International Announces First Quarter 2010 Results 10Yongye International Announces First Quarter 2010 Results 11Yongye International Announces First Quarter 2010 Results 12Yongye International Announces First Quarter 2010 Results 13Yongye International Announces First Quarter 2010 Results 14Max Neeman International Signs Agreement for Data Management/EDC of Large Phase IV Trials from Multiple Sites 2Resverlogix Completes Dosing for ASSERT Trial 2Resverlogix Completes Dosing for ASSERT Trial 3Resverlogix Completes Dosing for ASSERT Trial 4Resverlogix Completes Dosing for ASSERT Trial 5